Comments

Edgewise Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Edgewise Therapeutics (EWTX) operate in?

Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

EWTXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Edgewise Therapeutics (EWTX) Forecast

News Earnings Edgewise Therapeutics (EWTX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Edgewise Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:EWTX | Benzinga

Explore Edgewise Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for EWTX.

Open	$25.46
Close	-
Volume / Avg.	979.40K / 1.08M
Day Range	$23.84 - $26.40
52 Wk Range	14.90 - 38.12
Market Cap	$2.30B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	13.48%
Days to Cover	7.81

Recent News

Tesla, Micron, Broadcom, MARA Holdings And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease

Edgewise Therapeutics reports promising Phase 2 results for sevasemten, showing reduced muscle damage and well-tolerated safety in Becker muscular dystrophy.

Vandana Singh

Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$25.46
Close	-
Volume / Avg.	979.40K / 1.08M
Day Range	$23.84 - $26.40
52 Wk Range	14.90 - 38.12
Market Cap	$2.30B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	13.48%
Days to Cover	7.81

About Edgewise Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discov...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Edgewise Therapeutics (EWTX) stock?

You can purchase shares of Edgewise Therapeutics (NASDAQ:EWTX) through any online brokerage.

View our list of the best stock brokerages

Who are Edgewise Therapeutics (EWTX) competitors?

Other companies in Edgewise Therapeutics’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and ANI Pharmaceuticals (NASDAQ:ANIP).

What is the forecast, or price target, for Edgewise Therapeutics (EWTX) stock?

Edgewise Therapeutics has a consensus price target of $39.80.

What is the current price for Edgewise Therapeutics (EWTX)?

The stock price for Edgewise Therapeutics (NASDAQ: EWTX) is $24.3 last updated March 13, 2025 at 3:13 PM EDT.

Does Edgewise Therapeutics (EWTX) pay a dividend?

There are no upcoming dividends for Edgewise Therapeutics.

When is Edgewise Therapeutics (NASDAQ:EWTX) reporting earnings?

Edgewise Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Edgewise Therapeutics (EWTX) going to split?

There is no upcoming split for Edgewise Therapeutics.

What sector and industry does Edgewise Therapeutics (EWTX) operate in?

Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.